The first journal solely devoted to the world’s most neglected tropical diseases, PLOS Neglected Tropical Diseases publishes leading research and commentary on all scientific, medical, political and public health aspects of forgotten diseases affecting the world’s most neglected people.
PLOS Neglected Tropical Diseases publishes research devoted to the pathology, epidemiology, prevention, treatment and control of the neglected tropical diseases (NTDs), as well as relevant public policy.
The NTDs are defined as a group of poverty-promoting chronic infectious diseases, which primarily occur in rural areas and poor urban areas of low-income and middle-income countries. Their impact on child health and development, pregnancy, and worker productivity, as well as their stigmatizing features limit economic stability.
All aspects of these diseases are considered, including:
- Clinical features
- Pharmacology and treatment
- Vector biology
- Vaccinology and prevention
- Demographic, ecological and social determinants
- Public health and policy aspects (including cost-effectiveness analyses)
The journal focuses on human disease, not infections that only afflict livestock and other animals unless these diseases also impact human health and represent a public health problem. Further, we would like to reiterate that the focus of our journal is on translational or epidemiological studies, and less so on pure, basic molecular research not associated with the improvement of human health.
|Protozoan Infections (and their vectors)||
On the cusp:**
*The taxonomic position of the stramenopile-like, unicellular protist Blastocystis remains uncertain.
|Helminth Infections (and their vectors)||
All human helminth infections including but not restricted to:
|Viral Infections (and their vectors)||
On the cusp:**
|Bacterial Infections (and their vectors)||
On the cusp:**
On the cusp:**
Scabies, Myiasis, and other ectoparasites
On the cusp:**
Related topics with restricted scope
Papers that examine the link between nutrition and NTD infection are considered for PLOS Neglected Tropical Diseases.
HIV/AIDS, malaria, and tuberculosis
The “big three” diseases, HIV/AIDS, malaria, and tuberculosis, are not generally considered for PLOS Neglected Tropical Diseases. Submit research on these diseases to one of the six other PLOS journals as appropriate.
Fundamental microbial pathogenesis
Research on fundamental microbial pathogenesis and the molecular and cellular biology of the NTDs pathogens should be submitted to PLOS Pathogens. Examples: fundamental mechanisms of immune evasion by Plasmodium, blocking of apoptosis by Salmonella, population biology of Candida, or latency in herpes viruses.
Research on molecular pathways as potential drug or vaccine targets would be more suitable for PLOS Neglected Tropical Diseases.
Other research more suitable to PLOS Neglected Tropical Diseases includes health product (i.e., drug, diagnostic, and vaccine) development, human immunology, clinical manifestations, surveillance and epidemiologic research, public health control, and health policy aspects of the NTDs.
Other infectious diseases will also be considered on a case-by-case basis. Authors must indicate in the cover letter why they consider the infection to be a neglected tropical disease.
Research articles consider all aspects of the NTDs, including their pathogenesis, clinical features, pharmacology and treatment, diagnosis, epidemiology, vector biology, and vaccinology and prevention. Demographic, ecological and social determinants, public health, and policy aspects of these diseases (including cost-effectiveness analyses) are also a priority.
The Editorial is written by the Editor-in-Chief or a member of the Editorial Board.
The Viewpoints section contains opinion pieces grounded in evidence on topics of broad interest to the journal's readership.
The Policy Platform is for authors to discuss policies that could improve the lives of those at risk of, or affected by, the NTDs.
The Reviews section is for authors to summarize the best available evidence on a topic relevant to the NTD community.
In the Symposium section, authors discuss a “real world” problem, from the clinic, laboratory, or community, and how best it can be tackled.
As part of its mission to widen the distribution of scientific literature, PLOS is particularly concerned with the disparities in access to information between developed and developing countries. PLOS provides immediate, free, and unrestricted access to all the scientific and medical literature that it publishes. In addition, PLOS is also dedicated to establishing a medium for publishing science from the developing world. Thus, a major goal of PLOS Neglected Tropical Diseases is to promote and profile the efforts of researchers, health practitioners, and public-health experts in endemic countries in order to help build science and health capacity in those regions.
PLOS Neglected Tropical Diseases offers the following means of support to authors in developing countries:
Publication fee assistance. Read more.
Editorial support. PLOS Neglected Tropical Diseases is organized to provide additional editorial support for authors in developing countries. Manuscripts that are accepted for publication will receive additional support from our editorial staff or professionals from our partner organizations.
International Editorial Board. About 40% of our Associate Editors—who handle peer review of research articles—are based in developing countries. These experts understand the issues involved in confronting these diseases in their endemic settings, and they will help to ensure that the journal is a voice for researchers in these countries. See the Editorial Board.
Worldwide readership. As an Open Access journal, PLOS Neglected Tropical Diseases articles will always be freely available online via the journal Web site as well as through PubMed Central. Our content license means that readers are free to download, print, distribute, and translate your work, provided that they give you credit and cite the source. This means that your work will have the broadest possible audience: the entire world. And recent studies suggest that Open Access articles are downloaded and cited more frequently.
Influence. Your research has the chance to be highly influential. Select papers about neglected tropical diseases published in PLOS journals have been downloaded many thousands of times, have been mentioned in international news sources, and have had an important impact on health policy. For example, a paper in PLOS Medicine led to a UN mandate to integrate control of the NTDs into the UN's malaria control efforts.
To be considered for publication in PLOS Neglected Tropical Diseases, any given manuscript must satisfy the following criteria:
Importance and relevance to researchers, practitioners, or policy makers in the field of NTDs
Interest for researchers or practitioners outside the field
Rigorous methodology with conclusions justified by the evidence presented
Adherence to the highest ethical standards
Scientists commonly refer to research as “scooped” when independent groups working on the same topic reach similar conclusions and one group publishes the results first. Although originality is one criterion for studies published in PLOS Neglected Tropical Diseases, “scooped” manuscripts that confirm, replicate, extend, or are complementary to a recently published, significant advance are still eligible for consideration in PLOS Neglected Tropical Diseases. The complementary manuscript must present equally or more rigorous findings than the published study and any submission must also meet the criteria for publication listed above. Authors of the complementary work have six months after the first article’s publication date to submit their manuscript to PLOS Neglected Tropical Diseases. Studies must be performed comprehensively, and preliminary placeholder studies will not be considered.
The editorial process is run as a partnership between the PLOS Neglected Tropical Diseases Editors-in-Chief, the board of Deputy Editors, and a team of academic experts who act as Associate Editors (AEs). These individuals, all of whom are members of the PLOS Neglected Tropical Diseases Editorial Board, are leaders in their fields and represent the full breadth of research on NTDs.
PLOS Neglected Tropical Diseases publication fees vary based on article type and will be billed upon acceptance. Authors’ ability to pay publication fees will never be a consideration in the decision whether to publish. You can find a full list of our publication fees and fee assistance information here.
PLOS applies the Creative Commons Attribution (CC BY) license to works we publish. Under this license, authors agree to make articles legally available for reuse, without permission or fees, for virtually any purpose. Anyone may copy, distribute, or reuse these articles, as long as the author and original source are properly cited. Learn more.
PLOS does not consider Impact Factor to be a reliable or useful metric to assess the performance of individual articles. PLOS supports DORA – the San Francisco Declaration on Research Assessment – and does not promote our journal Impact Factors. We will provide the metric to individuals when specifically requested.
PLOS promotes the use of Article-Level Metrics (ALMs), which enable scientists and the general public to engage more dynamically with published research. ALMs reflect the changing impact of research over time, incorporate academic as well as social impacts of research, and assess the impact of research before the accrual of academic citations. Read more about ALMs.
See publishing details for all PLOS journal titles, including ISSN and indexing and archiving information.
PLOS is a nonprofit, Open Access publisher empowering researchers to accelerate progress in science and medicine by leading a transformation in research communication.
Visit the Contact page for details about whom to contact with different queries.